Cross-antagonism of a T cell clone expressing two distinct T cell receptors.

Inhibition of T cell activation can be mediated by analogs of the original antigenic peptide (TCR antagonists). Here, a T cell clone expressing two distinct TCR was used to investigate whether such inhibition involves an active mechanism by examining whether an antagonist for one TCR could influence responses stimulated by the other TCR engaging its agonist. Our results demonstrate functional cross-inhibition under these conditions involving the ability of antagonist: TCR interactions to diminish Lck enzymatic activity associated with the agonist-recognizing second TCR, apparently through enhancement of SHP-1 association with these receptors. Our findings reveal that inhibition of cellular responses by antagonists arises at least in part from active negative regulation of proximal TCR signaling and identify elements of the biochemical process.

[1]  T. McKeithan,et al.  Kinetic proofreading in T-cell receptor signal transduction. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[2]  K. Siminovitch,et al.  Signaling capacity of the T cell antigen receptor is negatively regulated by the PTP1C tyrosine phosphatase , 1996, The Journal of experimental medicine.

[3]  C. Walsh,et al.  Phosphorylation of Ser-42 and Ser-59 in the N-terminal region of the tyrosine kinase p56lck. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[4]  H. Ploegh,et al.  Peptide antagonism and T cell receptor interactions with peptide-MHC complexes. , 1998, Immunity.

[5]  Mark M. Davis,et al.  Ligand-specific oligomerization of T-cell receptor molecules , 1997, Nature.

[6]  H. Grey,et al.  Antigen analogs as tools to study T-cell activation function and activation. , 1996, Seminars in immunology.

[7]  Lars Fugger,et al.  Quantitative Analysis of Peptides from Myelin Basic Protein Binding to the MHC Class II Protein, I-Au, Which Confers Susceptibility to Experimental Allergic Encephalomyelitis , 1996, Molecular medicine.

[8]  A. Lanzavecchia,et al.  A T cell receptor (TCR) antagonist competitively inhibits serial TCR triggering by low‐affinity ligands, but does not affect triggering by high‐affinity anti‐CD3 antibodies , 1997, European journal of immunology.

[9]  C. Janeway,et al.  Ligands for the T-cell receptor: hard times for avidity models. , 1995, Immunology today.

[10]  Dan R. Littman,et al.  Signal transduction by lymphocyte antigen receptors , 1994, Cell.

[11]  C. Janeway,et al.  Peptide antagonists inhibit proliferation and the production of IL-4 and/or IFN-gamma in T helper 1, T helper 2, and T helper 0 clones bearing the same TCR. , 1997, Journal of immunology.

[12]  Antonio Lanzavecchia,et al.  T Cell Activation Determined by T Cell Receptor Number and Tunable Thresholds , 1996, Science.

[13]  C. Janeway,et al.  Both a monoclonal antibody and antisera specific for determinants unique to individual cloned helper T cell lines can substitute for antigen and antigen-presenting cells in the activation of T cells , 1983, The Journal of experimental medicine.

[14]  R. Germain,et al.  Relationships among TCR ligand potency, thresholds for effector function elicitation, and the quality of early signaling events in human T cells. , 1998, Journal of immunology.

[15]  Paul M. Allen,et al.  Partial T cell signaling: Altered phospho-ζ and lack of zap70 recruitment in APL-induced T cell anergy , 1994, Cell.

[16]  R. Germain,et al.  Peptide-major histocompatibility complex class II complexes with mixed agonist/antagonist properties provide evidence for ligand-related differences in T cell receptor-dependent intracellular signaling , 1993, The Journal of experimental medicine.

[17]  J. Altman,et al.  Initiation of signal transduction through the T cell receptor requires the multivalent engagement of peptide/MHC ligands [corrected]. , 1998, Immunity.

[18]  D. Fremont,et al.  High- and low-potency ligands with similar affinities for the TCR: the importance of kinetics in TCR signaling. , 1998, Immunity.

[19]  B. Malissen,et al.  Each of the two productive T cell receptor α-gene rearrangements found in both the A10 and BM 3.3 T cell clones give rise to an α chain which can contribute to the constitution of a surface-expressed αβ dimer , 1991 .

[20]  G. Crabtree,et al.  Signal transmission between the plasma membrane and nucleus of T lymphocytes. , 1994, Annual review of biochemistry.

[21]  R. Germain,et al.  Marked differences in the efficiency of expression of distinct alpha beta T cell receptor heterodimers. , 1989, Journal of immunology.

[22]  P. Allen,et al.  Fidelity of T cell activation through multistep T cell receptor zeta phosphorylation. , 1998, Science.

[23]  D. Wraith,et al.  An autoantigenic T cell epitope forms unstable complexes with class II MHC: a novel route for escape from tolerance induction. , 1993, International immunology.

[24]  C. Janeway,et al.  Surface expression of alpha 4 integrin by CD4 T cells is required for their entry into brain parenchyma , 1993, The Journal of experimental medicine.

[25]  R. Germain,et al.  Partial signaling by CD8+ T cells in response to antagonist ligands , 1996, The Journal of experimental medicine.

[26]  E. Palmer,et al.  T Cell Receptor (TCR) Antagonism without a Negative Signal: Evidence from T Cell Hybridomas Expressing Two Independent TCRs , 1999, The Journal of experimental medicine.

[27]  H. Metzger,et al.  An unusual mechanism for ligand antagonism. , 1998, Science.

[28]  H. Grey,et al.  Antigen analog-major histocompatibility complexes act as antagonists of the T cell receptor , 1992, Cell.

[29]  M. Davis,et al.  Kinetic discrimination in T-cell activation. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[30]  Y. Chien,et al.  A TCR binds to antagonist ligands with lower affinities and faster dissociation rates than to agonists. , 1996, Immunity.

[31]  C. Janeway,et al.  T cells with two functional antigen-specific receptors. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[32]  R. Germain,et al.  The Efficiency of CD4 Recruitment to Ligand-engaged TCR Controls the Agonist/Partial Agonist Properties of Peptide–MHC Molecule Ligands , 1997, The Journal of experimental medicine.

[33]  S. Jameson,et al.  T-cell-receptor affinity and thymocyte positive selection , 1996, Nature.

[34]  O. Acuto,et al.  Syk and ZAP-70 mediate recruitment of p56lck/CD4 to the activated T cell receptor/CD3/zeta complex , 1995, The Journal of experimental medicine.

[35]  L. Wahl,et al.  Lipopolysaccharide induces activation of CD14-associated protein tyrosine kinase p53/56lyn. , 1993, The Journal of biological chemistry.

[36]  P. Allen,et al.  Cutting edge: the tyrosine phosphatase SHP-1 regulates thymocyte positive selection. , 1999, Journal of immunology.

[37]  J. Fargnoli,et al.  Temporal regulation of non-transmembrane protein tyrosine kinase enzyme activity following T cell antigen receptor engagement. , 1994, The Journal of biological chemistry.

[38]  S. Jameson,et al.  Cutting edge: a test of the dominant negative signal model for TCR antagonism. , 1999, Journal of immunology.

[39]  A. Lanzavecchia,et al.  Serial triggering of many T-cell receptors by a few peptide–MHC complexes , 1995, Nature.

[40]  C. Walsh,et al.  Lck-dependent tyrosyl phosphorylation of the phosphotyrosine phosphatase SH-PTP1 in murine T cells , 1994, Molecular and cellular biology.

[41]  M. Bevan,et al.  T cell receptor antagonists and partial agonists. , 1995, Immunity.

[42]  Arthur Weiss,et al.  Genetic evidence for the involvement of the lck tyrosine kinase in signal transduction through the T cell antigen receptor , 1992, Cell.

[43]  Arthur Weiss,et al.  ZAP-70: A 70 kd protein-tyrosine kinase that associates with the TCR ζ chain , 1992, Cell.

[44]  R. Germain,et al.  Single Cell Analysis Reveals Regulated Hierarchical T Cell Antigen Receptor Signaling Thresholds and Intraclonal Heterogeneity for Individual Cytokine Responses of CD4+ T Cells , 1997, The Journal of experimental medicine.

[45]  P. Allen,et al.  Altered peptide ligand-induced partial T cell activation: molecular mechanisms and role in T cell biology. , 1996, Annual review of immunology.

[46]  H. Grey,et al.  Differential T cell signaling induced by antagonist peptide-MHC complexes and the associated phenotypic responses. , 1997, Journal of immunology.

[47]  L. Samelson,et al.  Zeta phosphorylation without ZAP-70 activation induced by TCR antagonists or partial agonists , 1995, Science.

[48]  D. Plas,et al.  Direct Regulation of ZAP-70 by SHP-1 in T Cell Antigen Receptor Signaling , 1996, Science.

[49]  A. Lanzavecchia,et al.  The duration of antigenic stimulation determines the fate of naive and effector T cells. , 1998, Immunity.